Stocktoria
HCW Biologics Inc. HCWB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-07-20
HCW Biologics Inc. statistics & valuation
Market cap$7.4M
P / B2.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 20.0% | 37.4% | 19.7% | 38.5% | — |
| Operating margin | -24270.7% | -1147.6% | -905.0% | -224.3% | — |
| Net margin | -14677.1% | -1169.7% | -879.5% | -221.7% | — |
| FCF margin | -24693.2% | -564.5% | -1010.5% | -307.4% | — |
| Return on assets | -32.5% | -99.3% | -87.7% | -31.8% | -24.0% |
| Return on equity | -287.9% | 443.5% | -185.7% | -39.8% | -25.1% |
| Debt / equity | 0.00× | -1.09× | 0.47× | 0.17× | 0.00× |
| Current ratio | 0.11 | 0.19 | 0.73 | 11.52 | 17.44 |
| Revenue growth | -97.9% | -9.7% | -57.7% | — | -100.0% |
Source: SEC EDGAR filings · CIK 0001828673 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.